These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 35154166)

  • 1. Decreased Expression of Programmed Death Ligand-L1 by Seven in Absentia Homolog 2 in Cholangiocarcinoma Enhances T-Cell-Mediated Antitumor Activity.
    Zheng H; Zheng WJ; Wang ZG; Tao YP; Huang ZP; Yang L; Ouyang L; Duan ZQ; Zhang YN; Chen BN; Xiang DM; Jin G; Fang L; Zhou F; Liang B
    Front Immunol; 2022; 13():845193. PubMed ID: 35154166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. M
    Qiu X; Yang S; Wang S; Wu J; Zheng B; Wang K; Shen S; Jeong S; Li Z; Zhu Y; Wu T; Wu X; Wu R; Liu W; Wang HY; Chen L
    Cancer Res; 2021 Sep; 81(18):4778-4793. PubMed ID: 34301762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corrigendum: Decreased expression of programmed death ligand-L1 by seven in absentia homolog 2 in cholangiocarcinoma enhances T-cell-mediated antitumor activity.
    Zheng H; Zheng WJ; Wang ZG; Tao YP; Huang ZP; Yang L; Ouyang L; Duan ZQ; Zhang YN; Chen BN; Xiang DM; Jin G; Fang L; Zhou F; Liang B
    Front Immunol; 2022; 13():1093403. PubMed ID: 36591292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hsa-LINC02418/mmu-4930573I07Rik regulated by METTL3 dictates anti-PD-L1 immunotherapeutic efficacy via enhancement of Trim21-mediated PD-L1 ubiquitination.
    Sun Z; Mai H; Xue C; Fan Z; Li J; Chen H; Huo N; Kang X; Tang C; Fang L; Zhao H; Han Y; Sun C; Peng H; Du Y; Yang J; Du N; Xu X
    J Immunother Cancer; 2023 Dec; 11(12):. PubMed ID: 38040417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. WTAP-induced N
    Liu QZ; Zhang N; Chen JY; Zhou MJ; Zhou DH; Chen Z; Huang ZX; Xie YX; Qiao GL; Tu XH
    Cancer Sci; 2024 Jun; 115(6):1749-1762. PubMed ID: 38508217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N6-methyladenosine-modified circSLCO1B3 promotes intrahepatic cholangiocarcinoma progression via regulating HOXC8 and PD-L1.
    Li J; Xu X; Xu K; Zhou X; Wu K; Yao Y; Liu Z; Chen C; Wang L; Sun Z; Jiao D; Han X
    J Exp Clin Cancer Res; 2024 Apr; 43(1):119. PubMed ID: 38641828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of T-cell-mediated immune response via the PD-1/ PD-L1 axis in cholangiocarcinoma cells.
    Suriyo T; Fuangthong M; Artpradit C; Ungtrakul T; Sricharunrat T; Taha F; Satayavivad J
    Eur J Pharmacol; 2021 Apr; 897():173960. PubMed ID: 33617828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N
    Liu Z; Wang T; She Y; Wu K; Gu S; Li L; Dong C; Chen C; Zhou Y
    Mol Cancer; 2021 Aug; 20(1):105. PubMed ID: 34416901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. JNK Signaling Promotes Bladder Cancer Immune Escape by Regulating METTL3-Mediated m6A Modification of PD-L1 mRNA.
    Ni Z; Sun P; Zheng J; Wu M; Yang C; Cheng M; Yin M; Cui C; Wang G; Yuan L; Gao Q; Li Y
    Cancer Res; 2022 May; 82(9):1789-1802. PubMed ID: 35502544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. METTL14 regulates CD8
    Sun C; Wang J; Li H; Liu L; Lin Y; Zhang L; Zu X; Zhu Y; Shu Y; Shen D; Wang Q; Liu Y
    World J Surg Oncol; 2024 May; 22(1):128. PubMed ID: 38725005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of vitamin B6 as a PD-L1 suppressor and an adjuvant for cancer immunotherapy.
    Yuan J; Li J; Shang M; Fu Y; Wang T
    Biochem Biophys Res Commun; 2021 Jul; 561():187-194. PubMed ID: 34023785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. METTL14-mediated N6-methyladenosine modification of SOX4 mRNA inhibits tumor metastasis in colorectal cancer.
    Chen X; Xu M; Xu X; Zeng K; Liu X; Pan B; Li C; Sun L; Qin J; Xu T; He B; Pan Y; Sun H; Wang S
    Mol Cancer; 2020 Jun; 19(1):106. PubMed ID: 32552762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of m6A-mediated PD-1/PD-L1 in antitumor immunity.
    Liu L; Liang L; Li H; Shao W; Yang C; Lin F; Liu J; Zhang J
    Biochem Pharmacol; 2023 Apr; 210():115460. PubMed ID: 36822438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Siah2- and LRSAM1-mediated K63-linked ubiquitination of snakehead vesiculovirus nucleoprotein facilitates viral replication.
    Jiang N; Zhao H; Qin X; Zhang Y-A; Tu J
    J Virol; 2024 Jul; 98(7):e0020224. PubMed ID: 38842318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unveiling the promise of PD1/PD-L1: A new dawn in immunotherapy for cholangiocarcinoma.
    Chen F; Sheng J; Li X; Gao Z; Zhao S; Hu L; Chen M; Fei J; Song Z
    Biomed Pharmacother; 2024 Jun; 175():116659. PubMed ID: 38692063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of Siah2 in tumorigenesis and cancer therapy.
    Li K; Li J; Ye M; Jin X
    Gene; 2022 Jan; 809():146028. PubMed ID: 34687788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. METTL14-mediated N
    Liu Z; Sun T; Piao C; Zhang Z; Kong C
    Cell Commun Signal; 2022 Mar; 20(1):36. PubMed ID: 35305660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Programmed Death Ligand 1 Regulatory Crosstalk with Ubiquitination and Deubiquitination: Implications in Cancer Immunotherapy.
    Kim SB; Hwang S; Cha JY; Lee HJ
    Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N6-methyladenosine RNA modification in PD-1/PD-L1: Novel implications for immunotherapy.
    Luo P; Li S; Long X
    Biochim Biophys Acta Rev Cancer; 2023 May; 1878(3):188873. PubMed ID: 36842764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Expression of the Ubiquitin Ligase SIAH2 (Seven In Absentia Homolog 2) Is Increased in Human Lung Cancer.
    Moreno P; Lara-Chica M; Soler-Torronteras R; Caro T; Medina M; Álvarez A; Salvatierra Á; Muñoz E; Calzado MA
    PLoS One; 2015; 10(11):e0143376. PubMed ID: 26580787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.